AP2444A - New benzothiazinone derivatives and their use as antibacterial agents - Google Patents

New benzothiazinone derivatives and their use as antibacterial agents

Info

Publication number
AP2444A
AP2444A AP2008004723A AP2008004723A AP2444A AP 2444 A AP2444 A AP 2444A AP 2008004723 A AP2008004723 A AP 2008004723A AP 2008004723 A AP2008004723 A AP 2008004723A AP 2444 A AP2444 A AP 2444A
Authority
AP
ARIPO
Prior art keywords
antibacterial agents
new
benzothiazinone derivatives
derivatives
new benzothiazinone
Prior art date
Application number
AP2008004723A
Other languages
English (en)
Other versions
AP2008004723A0 (en
Inventor
Vadim A Makarov
Stewart T Cole
Ute Mollmann
Original Assignee
Leibniz Inst For Natural Product Res Andinfection Biology Ev Hans Knoll Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leibniz Inst For Natural Product Res Andinfection Biology Ev Hans Knoll Inst filed Critical Leibniz Inst For Natural Product Res Andinfection Biology Ev Hans Knoll Inst
Publication of AP2008004723A0 publication Critical patent/AP2008004723A0/xx
Application granted granted Critical
Publication of AP2444A publication Critical patent/AP2444A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2008004723A 2006-05-24 2006-05-24 New benzothiazinone derivatives and their use as antibacterial agents AP2444A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2006/004942 WO2007134625A1 (en) 2006-05-24 2006-05-24 New benzothiazinone derivatives and their use as antibacterial agents

Publications (2)

Publication Number Publication Date
AP2008004723A0 AP2008004723A0 (en) 2008-12-31
AP2444A true AP2444A (en) 2012-08-31

Family

ID=37595033

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004723A AP2444A (en) 2006-05-24 2006-05-24 New benzothiazinone derivatives and their use as antibacterial agents

Country Status (24)

Country Link
US (2) US7863268B2 (xx)
EP (1) EP2029583B1 (xx)
JP (1) JP5068813B2 (xx)
KR (1) KR101314999B1 (xx)
CN (1) CN101472922B (xx)
AP (1) AP2444A (xx)
AT (1) ATE470667T1 (xx)
AU (1) AU2006343832B2 (xx)
BR (1) BRPI0621693B8 (xx)
CA (1) CA2652841C (xx)
CR (1) CR10519A (xx)
CY (1) CY1110769T1 (xx)
DE (1) DE602006014885D1 (xx)
DK (1) DK2029583T3 (xx)
EA (1) EA015910B1 (xx)
ES (1) ES2345902T3 (xx)
IL (1) IL195453A (xx)
MX (1) MX2008014958A (xx)
NZ (1) NZ573833A (xx)
PL (1) PL2029583T3 (xx)
PT (1) PT2029583E (xx)
SI (1) SI2029583T1 (xx)
TN (1) TNSN08474A1 (xx)
WO (1) WO2007134625A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008014958A (es) 2006-05-24 2009-04-15 Leibniz Inst For Natural Produ Nuevos derivados de benzotiazinona y su uso como agentes antibacterianos.
EP2020406A1 (en) * 2007-07-16 2009-02-04 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut New antimicrobial compounds, their synthesis and their use for treatment of mammalian infection
RU2474621C2 (ru) * 2008-02-13 2013-02-10 Сентинель Сх С.П.А. Новая эффективная лекарственная мишень для лечения туберкулеза
EP2380886A1 (en) 2010-04-23 2011-10-26 Vadim A. Makarov Process for the preparation of 2-aminosubstituted 1,3-benzothiazine-4-ones
JP6061346B2 (ja) * 2010-11-19 2017-01-18 エコール ポリテクニーク フェデラル ドゥ ローザンヌ (イーピーエフエル) 2−ピペラジン−1−イル−4h−1,3−ベンゾチアジン−4−オン誘導体、および哺乳類の感染症治療へのその使用
EP2468746A1 (en) 2010-12-23 2012-06-27 The University of Queensland Benzothiazinone compounds and their use as anti-tuberculosis agents
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
CN102276598B (zh) * 2011-05-27 2014-11-05 四川大学 苯并噻嗪硫酮衍生物及其制备方法和用途
CN102367239B (zh) * 2011-07-20 2015-10-28 沈阳药科大学 2-芳基-2,3-二氢-4h-1,3-苯并噻嗪-4-酮衍生物及其用途
EP2570413A1 (en) 2011-09-15 2013-03-20 The University Of Queensland Benzothiazinone derivatives as anti-tuberculosis agents
CN103508980B (zh) * 2012-06-14 2016-07-06 四川大学 苯并噻嗪-4-酮衍生物及其制备方法和用途
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
CN104211708B (zh) * 2013-05-29 2018-08-24 中国医学科学院药物研究所 苯并噁嗪酮衍生物及其作为抗菌剂的应用
CN108051590B (zh) 2013-09-13 2020-12-11 Symbolics有限责任公司 运用二维试验和对照信号读出模式的侧向层析检测
CN105705486B (zh) 2013-11-18 2019-03-01 格里洛工厂股份有限公司 用于自烷烃和发烟硫酸制备烷基磺酸的新型引发剂
DE102014012546A1 (de) * 2014-09-26 2016-03-31 Martin-Luther-Universität Halle-Wittenberg Antimykobakteriell wirksame Substanzen, Verfahren zu ihrer Herstellung und deren Verwendung
EP3072889A1 (en) 2015-03-23 2016-09-28 Ecole Polytechnique Federale De Lausanne (Epfl) 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides
CN105669664B (zh) * 2016-02-19 2019-05-10 浙江司太立制药股份有限公司 含有碱性氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法
CN105622596B (zh) * 2016-02-19 2018-10-30 浙江司太立制药股份有限公司 含有烷氧亚胺基氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法
US11155542B2 (en) 2016-09-22 2021-10-26 University Of Notre Dame Du Lac Antimicrobial compounds, their use for the treatment of mammalian infections and a new metabolic mechanism
RU2663848C1 (ru) * 2018-03-23 2018-08-10 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) 5-Фтор-2-(4-этоксикарбонилпиперазин-1-ил)-1,3-бензотиазин-4-он, обладающий противотуберкулезной активностью
CN111269197A (zh) * 2020-04-08 2020-06-12 苏州大学 苯并噻嗪酮化合物及其制备方法与作为抗结核药物的应用
CN113121521B (zh) * 2021-03-26 2022-11-04 苏州大学 6-位三氟甲基取代的苯并噻嗪酮衍生物及其制备方法与应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522247A (en) * 1967-11-07 1970-07-28 Pfizer & Co C 2-amino-6,7-disubstituted-4h-1,3-benzothiazine-4-ones as bronchodilators
WO2005092872A1 (en) * 2004-03-26 2005-10-06 Arpida A/S Peptide deformylase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470168A (en) * 1967-03-31 1969-09-30 American Home Prod 2-substituted-4h-1,3-benzothiazin-4-one derivatives
GB8611617D0 (en) 1986-05-13 1986-06-18 Shell Int Research Fungicides
WO2000051992A1 (en) 1999-03-04 2000-09-08 E.I. Du Pont De Nemours And Company Fused bicyclic oxazinone and thiazinone fungicides
EP1312607A1 (en) 2001-11-17 2003-05-21 MEDAC GmbH Dithiocarbamate derivatives and their use as antibacterial agents
AU2003289176A1 (en) 2002-12-05 2004-07-29 Takeda Pharmaceutical Company Limited 1,3-benzothiazinone derivatives, process for producing the same and use thereof
MX2008014958A (es) 2006-05-24 2009-04-15 Leibniz Inst For Natural Produ Nuevos derivados de benzotiazinona y su uso como agentes antibacterianos.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522247A (en) * 1967-11-07 1970-07-28 Pfizer & Co C 2-amino-6,7-disubstituted-4h-1,3-benzothiazine-4-ones as bronchodilators
WO2005092872A1 (en) * 2004-03-26 2005-10-06 Arpida A/S Peptide deformylase inhibitors

Also Published As

Publication number Publication date
MX2008014958A (es) 2009-04-15
WO2007134625A1 (en) 2007-11-29
ATE470667T1 (de) 2010-06-15
BRPI0621693B1 (pt) 2020-11-17
EA200870564A1 (ru) 2009-06-30
TNSN08474A1 (en) 2010-04-14
EP2029583A1 (en) 2009-03-04
ES2345902T3 (es) 2010-10-05
EP2029583B1 (en) 2010-06-09
US20090239851A1 (en) 2009-09-24
JP2009537576A (ja) 2009-10-29
CA2652841A1 (en) 2007-11-29
PL2029583T3 (pl) 2010-10-29
KR101314999B1 (ko) 2013-10-04
KR20090029736A (ko) 2009-03-23
JP5068813B2 (ja) 2012-11-07
AU2006343832A1 (en) 2007-11-29
NZ573833A (en) 2010-10-29
IL195453A0 (en) 2009-08-03
US7863268B2 (en) 2011-01-04
DK2029583T3 (da) 2010-09-27
DE602006014885D1 (de) 2010-07-22
CA2652841C (en) 2015-01-27
EA015910B1 (ru) 2011-12-30
CR10519A (es) 2009-04-14
CN101472922B (zh) 2012-05-30
BRPI0621693B8 (pt) 2021-05-25
CY1110769T1 (el) 2015-06-10
CN101472922A (zh) 2009-07-01
SI2029583T1 (sl) 2010-09-30
IL195453A (en) 2013-01-31
BRPI0621693A2 (pt) 2011-12-20
US20110160193A1 (en) 2011-06-30
AP2008004723A0 (en) 2008-12-31
PT2029583E (pt) 2010-08-12
AU2006343832B2 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
AP2444A (en) New benzothiazinone derivatives and their use as antibacterial agents
GB0612428D0 (en) Antibacterial agents
TWI561237B (en) Substituted dihydropyrazolones and their use
IL184844A0 (en) ??-cyclodextrin derivatives as antibacterial agents
HK1208000A1 (en) Thioninium compounds and their use
AP2654A (en) Quinoline derivatives as antibacterial agents
AP2007004264A0 (en) Quinoline derivatives as antibacterial agents
EP2007377A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
HK1132731A1 (en) Substituted chromanol derivatives and their use
HK1127614A1 (en) Aminothiazole derivatives and their uses as antibacterial agents
GB0611115D0 (en) Compounds and their use
ZA200808035B (en) Antibacterial agents
HK1120732A1 (en) Quinoline derivatives as antibacterial agents
AP2483A (en) Quinoline derivatives as antibacterial agents
EP1968569A4 (en) BENZOPYRANONE DERIVATIVES AND THEIR USE AS ANTI-CORONAVIRUS AGENTS
IL188394A0 (en) Quinoline derivatives as antibacterial agents
GB0619611D0 (en) Compounds and their use
ZA200810642B (en) New benzothiazinone derivatives and their use as antibacterial agents
HU0600122D0 (en) New compounds and their use
GB0623070D0 (en) Antibacterial agents
GB0616577D0 (en) Compounds and their use
GB0603378D0 (en) Compounds and their use
GB0608846D0 (en) Compounds and their use
GB0603376D0 (en) Compounds and their use
GB0610888D0 (en) Compounds and their use